According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...

Senores Pharmaceuticals IPO Day 3 Highlights: Senores Pharmaceuticals' initial public offering (IPO) closed for subscription on Tuesday, December 24, having been subscribed 93.41 times.

Senores Pharmaceuticals share price listed at stellar 53% premium at ₹600 on the NSE and ₹593.70 on the BSE on Monday ...

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...

Senores Pharmaceuticals Share Price Live Updates: Senores Pharmaceuticals shares made their Dalal Street debut today after high demand for its initial public offering (IPO). Senores ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) Senores Pharmaceuticals IPO closes ...

Senores Pharmaceuticals Share Price, IPO Listing Live: The company raised Rs 260.63 crore from anchor investors. (Image: Freepik) Senores Pharmaceuticals Share Price, IPO Listing Highlights ...

Bajaj Broking notes that Senores Pharmaceuticals is well-positioned within the growing pharmaceutical industry, especially in the post-pandemic era. The sector continues to witness robust demand, ...

Senores Pharmaceuticals stock debuts on the NSE at ₹600.00, registering a robust 53.5 per cent premium against the IPO price of ₹391. The stock touched an intraday high of ₹609.65 ...

The Ahmedabad-based Senores Pharmaceuticals, which launched its ₹582.11 crore IPO on Friday, at a price band of ₹372-391, saw a strong response on Day 1 with a subscription of 1.78 times.

Senores Pharmaceuticals has filed red herring prospectus with the Registrar of Companies as it plans to launch IPO for public subscription on December 20. The company will disclose price band ...

Senores Pharmaceuticals Ltd. engaged in developing and manufacturing generic pharmaceutical products in the B2B segment for U.S., Canada and United Kingdom and Emerging Markets, has announced to ...